Add Yahoo as a preferred source to see more of our stories on Google. Many patients who contracted mpox during the 2022 outbreak experienced physical effects more than a year later, a new study ...

More than half of individuals with mpox reported persistent physical and psychosocial sequelae 11 to 18 months after acute infection.

Patients with acute mpox infections experienced persistent physical, behavioral, and psychosocial side effects more than a year after illness, a cohort study suggested. Among 154 people with clade II ...

The 2022 mpox outbreak caught many off guard, quickly spreading beyond endemic areas in Africa to other parts of the world, including Europe and North America. The World Health Organization (WHO) ...

Osmundson is a clinical assistant professor of biology at New York University and author of “Virology.” Paredes is an infectious disease epidemiologist at the University of Washington. As queer ...

A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to get the full newsletter in your inbox, including answers to reader ...

The World Health Organization announced Friday it has authorized the use of an mpox vaccine, calling it an “important step” in the fight against the disease. The move could help national regulatory ...

The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General's ...

Many patients who contracted mpox during the 2022 outbreak experienced physical effects more than a year later, a new study published on Monday finds. Researchers from the Centers for Disease Control ...